BIOGEN INC. (BIIB)
TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region
TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors
Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%
Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region
BWXT Bolsters American Nuclear Manufacturing Capability With Strategic Acquisition
Volition Launches rNuQ™ Webshop Broadening Product Range
DEFSEC Announces Board Changes, Strengthening Strategic Leadership
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram